Total Valuation
BetterLife Pharma has a market cap or net worth of €95.04M. The enterprise value is €51.90M.
Market Cap€95.04M
Enterprise Value€51.90M
Share Statistics
BetterLife Pharma has 618,007,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding618,007,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BetterLife Pharma’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 32.40%.
Return on Equity (ROE)0.15
Return on Assets (ROA)-6.80
Return on Invested Capital (ROIC)32.40%
Return on Capital Employed (ROCE)0.28
Revenue Per Employee0.00
Profits Per Employee-378.23K
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BetterLife Pharma is ―. BetterLife Pharma’s PEG ratio is 0.08.
PE Ratio―
PS Ratio0.00
PB Ratio-0.75
Price to FCF-11.66
Price to Operating Cash Flow-17.15
PEG Ratio0.08
Income Statement
In the last 12 months, BetterLife Pharma had revenue of 0.00 and earned -1.50M in profits. Earnings per share was -0.01.
Revenue0.00
Gross Profit0.00
Operating Income-1.81M
Pretax Income-1.51M
Net Income-1.50M
EBITDA-1.81M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -2.08M and capital expenditures 0.00, giving a free cash flow of -2.08M billion.
Operating Cash Flow-2.08M
Free Cash Flow-2.08M
Free Cash Flow per Share>-0.01
Dividends & Yields
BetterLife Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.33
52-Week Price Change327.27%
50-Day Moving Average0.19
200-Day Moving Average0.08
Relative Strength Index (RSI)42.90
Average Volume (3m)13.96K
Important Dates
BetterLife Pharma upcoming earnings date is Dec 17, 2026, TBA (Confirmed).
Last Earnings DateSep 29, 2026
Next Earnings DateDec 17, 2026
Ex-Dividend Date―
Financial Position
BetterLife Pharma as a current ratio of 0.03, with Debt / Equity ratio of -22.92%
Current Ratio0.03
Quick Ratio0.03
Debt to Market Cap0.12
Net Debt to EBITDA-0.49
Interest Coverage Ratio-7.80
Taxes
In the past 12 months, BetterLife Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BetterLife Pharma EV to EBITDA ratio is -4.53, with an EV/FCF ratio of -13.09.
EV to Sales0.00
EV to EBITDA-4.53
EV to Free Cash Flow-13.09
EV to Operating Cash Flow-13.09
Balance Sheet
BetterLife Pharma has €973.59K in cash and marketable securities with €2.51M in debt, giving a net cash position of -€1.54M billion.
Cash & Marketable Securities€973.59K
Total Debt€2.51M
Net Cash-€1.54M
Net Cash Per Share>-€0.01
Tangible Book Value Per Share-€0.04
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for BetterLife Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-248.72%